Addex Therapeutics (XSWX:ADXN) Beginning Cash Position : CHF4.75 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Beginning Cash Position?

Addex Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was CHF4.75 Mil.

Addex Therapeutics's quarterly Beginning Cash Position increased from Jun. 2023 (CHF5.59 Mil) to Sep. 2023 (CHF7.17 Mil) but then declined from Sep. 2023 (CHF7.17 Mil) to Dec. 2023 (CHF4.75 Mil).

Addex Therapeutics's annual Beginning Cash Position increased from Dec. 2021 (CHF18.70 Mil) to Dec. 2022 (CHF20.48 Mil) but then declined from Dec. 2022 (CHF20.48 Mil) to Dec. 2023 (CHF6.96 Mil).

Addex Therapeutics Beginning Cash Position Historical Data

The historical data trend for Addex Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Beginning Cash Position Chart

Addex Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

41.67

31.54

18.70

20.48

6.96

Addex Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															10.42	6.96	5.59	7.17	4.75

Addex Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Addex Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Addex Therapeutics (XSWX:ADXN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ADXN:USA ADXNz:UK APE1:Germany

Address

Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202

Website

https://www.addextherapeutics.com

Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire • 02-24-2021

Thinking about buying stock in Applovin, Sonos, WiMi Hologram Cloud, Addex Therapeutics, or Snap?

By PRNewswire PRNewswire • 02-09-2023